
Interstitial Lung Disease (ILD) Pathway Development
Primary Care / Family Medicine
2025-01-02 – Present
This project focuses on the development of physician- and patient-facing education and support materials to guide appropriate responses, follow-up, and interventions for radiology-reported incidental findings of Interstitial Lung Abnormalities (ILAs) identified on CT scans. ILAs may be indicative of early or subclinical Interstitial Lung Disease (ILD) and can present challenges related to variability in reporting, follow-up, and referral practices.
Initially launched as a Calgary initiative, the project is intended to establish a foundational pathway that can be scaled and spread provincially, with applicability across both specialist and general radiology settings. Led by Dr. Amanda Grant-Orser, this work is being advanced in collaboration with the Foothills Medical Centre Interstitial Lung Disease Clinic, ensuring alignment with specialist expertise and current clinical practice.
The proposed pathway will be designed to function as both a clinical decision support tool and a knowledge translation mechanism, supporting physicians in evidence-informed follow-up care, referral decisions, and patient communication. Emerging and forthcoming guidance, including anticipated updates from the American Thoracic Society, will be integrated into pathway content and associated materials as appropriate.
The project transitioned from early planning into active engagement, completing a needs assessment with radiologists, family physicians, and respirologists, as well as a patient engagement phase that included interviews and lived‑experience perspectives. A multidisciplinary design group convened a series of focus groups to review early findings, validate care gaps, and inform next steps. Two of the three planned focus groups have been completed and were attended by medical leadership, including PLP Medical Directors Drs. Katrina Nicholson and Oliver David. The second focus group incorporated patient participants, ensuring patient perspectives are embedded in ongoing pathway development.
Insights from this engagement are informing PLP’s next phase of work, including exploration of tools and resources to support clinicians receiving CT reports identifying ILAs, patient-facing information to clarify findings and next steps, and educational supports to build confidence in community-based ILD assessment, triage, and follow-up. Together, these efforts represent early but important progress toward a more coordinated, evidence-informed approach to the management of incidental ILAs.
A coordinated, evidence-informed pathway will support physician management of incidental ILAs, strengthening follow-up, referral, and patient communication while enabling early system alignment and potential for provincial scale and spread.